Read the temporary program’s own terms
The terms checked September 26, 2026 scheduled the Medicare program to begin July 1, 2026 and end December 31, 2027.
Who could qualify?
Under terms checked September 26, 2026, you needed to be at least 18 and have qualifying Medicare drug coverage.
Eligibility depended on how your weight compared with your height; in some cases, other health conditions mattered too.
The Bridge excluded patients who had type 2 diabetes, since ordinary Medicare drug coverage handled their treatment.
Other exclusions also applied, including getting one of these medicines through a Medicare drug plan earlier in 2026.
Ask your doctor to check the full requirements for you, including the kind of Medicare plan you have.
Which medicines were included?
Under the September 26, 2026 terms, the included forms were Wegovy (semaglutide) as shots or tablets; Foundayo (orforglipron) as tablets; and Zepbound (tirzepatide) using KwikPen.
These are medicine names; KwikPen is the name of an injection pen.
Zepbound in other pens or small bottles was not included.
You needed a prescription and approval from the program before getting the medicine.
Ask your doctor how to send the Bridge request, rather than treating its price as your price before approval.
Read Medicare’s weight-medicine coverage page ↗